- Company/Commercial (571)
- Corporate (465)
- Litigation / Dispute Resolution (411)
- Banking / Finance (334)
- Regulatory and compliance (295)
- Tax (237)
- Information Technology (229)
- Employment (209)
- Intellectual Property (173)
- Financial services (171)
- Real Estate (145)
- Healthcare (130)
- Funds (125)
- Energy (106)
- Media/Entertainment/Sport (103)
- Commodities (68)
- Crime (66)
- Insurance/reinsurance (64)
- Construction (60)
- Environment (59)
- Insolvency & restructuring (59)
- Business Tax (53)
- Pharma/Biotech (52)
- PPP/PFI/Commercial projects (50)
- Transport (Including aviation and shipping) (50)
- Clinical/Medical Negligence (46)
- Telecoms (42)
- Private Equity (41)
- Competition/EU (39)
- Privacy and reputation (36)
- Licensing/Gaming/Betting (33)
- Charities (28)
- Human Rights (28)
- Planning (21)
- Public Sector/Local Authority (18)
- Pensions (16)
- Travel and Tourism (15)
- Other (14)
- Family (13)
- Agriculture (11)
- Personal tax / Trusts (10)
- Professional Indemnity/Negligence (7)
- Immigration (6)
- In-House (5)
- Personal Injury (1)
- Private Client (1)
- Sovereign Wealth (1)
- Suppliers (1)
1620 articles matched your search
Sort By: Newest first | Oldest first
A well-known British performing artist was granted permission to take his case to the Supreme Court, where he will appeal the Court of Appeal’s decision in OPO v MLA & STL.
The increased focus of national data protection authorities on the processing of personal data through mobile apps was again confirmed in an open letter from a group of data protection authorities.
Global Insight — Spanish insolvency laws; retention of title in the UK; portfolio transactions; and more
Global Insight is a digital publication bringing you news, views and analysis from DLA Piper’s global restructuring group.
The European Union member states are preparing to introduce a new European Patent with Unitary Effect and a single Unified Patent Court with divisions located throughout Europe.
California’s Insurance Fraud Prevention Act: three unsettled issues the health sector should understand
California’s Insurance Frauds Prevention Act, Ins. Code §§ 1871 et seq. (IFPA), is an unusual false claims statute.
Patents directed to genetic material have been the subject of significant public discourse and legal challenge worldwide.
A court ruled in the case of a plaintiff who claimed his privacy rights had been violated because Google search engine results of his name included news articles suggesting he had a criminal past.
This briefing from DLA Piper discusses three key intellectual property and technology cases: Kimble v Marvel Enterprises, B&B Hardware, inc v Hargis Industries and Teva Pharmaceuticals v Sandoz.
The Supreme Court ruled in FTC v Actavis that settlement agreements for patent infringement suits between branded and generic drug companies are not immune from antitrust scrutiny.
Arguably, Germany is the jurisdiction that has the most to lose with the introduction of the UPC.